BPC-157
BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.
01Dosing reference
02Mechanism of action
Angiogenesis Stimulation
BPC-157 upregulates vascular endothelial growth factor (VEGF) and other angiogenic pathways, promoting the formation of new blood vessels.
Fibroblast Activation
It accelerates the migration and proliferation of fibroblasts, which are crucial cells for synthesizing collagen and extracellular matrix in damaged tissues.
Tissue Regeneration
Enhanced blood flow and cellular repair mechanisms lead to accelerated healing of musculoskeletal injuries and protection of the gastric mucosa.
03Human evidence
Potential benefits in inflammatory bowel disease (IBD)
Early clinical observations and phase I/II trials have explored oral BPC-157 for ulcerative colitis, showing safety and potential mucosal healing, though large-scale phase III data is lacking.
Anecdotal and limited clinical reports of joint and tendon recovery
While widely used off-label by athletes for injury recovery, robust, peer-reviewed, large-scale human clinical trials specifically for musculoskeletal healing remain scarce.
04Preclinical evidence
Accelerated healing of transected Achilles tendons
In rat models, BPC-157 administration significantly improved the biomechanical properties and structural organization of healing tendons compared to controls.
Protection against NSAID-induced gastric ulcers
Animal studies demonstrate that BPC-157 can prevent and heal gastric lesions caused by non-steroidal anti-inflammatory drugs (NSAIDs) by maintaining mucosal integrity.
Enhanced muscle and nerve regeneration
Rodent models of crush injuries showed that BPC-157 promoted muscle healing and accelerated the recovery of peripheral nerve function.
05What is known vs. unknown
- Derived from a naturally occurring peptide found in human gastric juice.
- Demonstrates potent angiogenic properties, stimulating the formation of new blood vessels to aid tissue repair.
- Highly effective in animal models for healing tendons, ligaments, and muscles.
- Shows significant gastroprotective effects, particularly against NSAID-induced damage in preclinical studies.
- Lack of large-scale, randomized, double-blind, placebo-controlled human trials for musculoskeletal injuries.
- Long-term safety profile and potential risks of systemic angiogenesis stimulation in humans are not fully understood.
- Optimal dosing protocols and delivery methods (oral vs. subcutaneous) for specific human conditions remain unstandardized.
06Safety & regulatory context
07Compared with TB-500 (Thymosin Beta-4)
08Appears in protocols
09Glossary
10Knowledge check
11Sources
More in Healing & Recovery
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.
KPV
KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.
Wolverine Blend (BPC-157 + TB-500)
The 'Wolverine Blend' is a popular research combination of two well-known healing peptides: BPC-157 and TB-500 (Thymosin Beta-4). Research suggests that BPC-157 promotes angiogenesis and gastrointestinal healing, while TB-500 upregulates actin, facilitating cell migration and tissue repair. Together, they are studied for their synergistic potential in accelerating recovery from muscle, tendon, and ligament injuries.